Introduction
to kill specifically tumour cells that express HSP70 at the cell surface [8, 9] . In accordance with this stimulatory property of HSP70, we observed in a xenograft model [10] [11, 12] . The HSP70-overexpressing melanoma cells released HSP70-containing exosomes and these exosomes were able to stimulate mouse NK cells in vitro to kill target cells expressing NKG2D ligands [10] .
Now we wanted to analyse at the molecular level whether indeed the HSP70 protein itself is able to stimulate NK cells to kill target cells which express NKG2D ligands such as MICA (major histocompatibility complex class I chain-related molecule A). Furthermore, we addressed the question whether both stressinducible danger signals, HSP70 and MICA/B, jointly augment the cytotoxicity of human NK cells. We performed experiments with human NK cells as effectors and as targets MICA-transfected L cells. In addition, we analysed the human melanoma cells that we have studied previously in a mouse xenograft model [10] as targets for HSP70-activated human NK cells. The obtained results clearly confirm the relevance of the concerted action of HSP70 and MICA for activation of human NK cells against tumour cells. A combination of both danger signals, HSP70 and MICA, might be exploitable for immunotherapy of human cancer.

Materials and methods
Target cell lines and cell culture
The human melanoma cell lines Ge-Hsp70 (clone Ge-Hsp70-A) and Ge-con (clone Ge-TCR-C) [10, 13] , human erythroleukaemia K562 cells, mouse fibroblast L cells, MICA and empty vector-transfected L cells were maintained under standard conditions described previously [10, 13] . To induce MICA/B expression, the melanoma cells were cultured in Dulbecco's modified Eagle's medium (DMEM) with 10 M of the histone deacetylase inhibitor suberoylanilide hydroxyamic acid (SAHA) (Qbiogene-Alexis, Grünberg, Germany) 20 hrs before being used for experiments [14] . Mouse L cells were co-transfected by electroporation with 30 g of the cosmid A158 [15] containing the MICA gene of the rhesus macaque (Macaca mulatta) [16] , and with 1 g of the DsRed vector (Clontech, Heidelberg, Germany) 
Recombinant HSP70 and HSC70
The His-tagged recombinant HSP70 protein derived from the rat Hsp70-1 gene has been previously described [17] [17] . Endotoxin-free recombinant human HSP70 was produced as a secreted protein in an eukaryotic expression system as described elsewhere [18] (Fig. 5A) . Importantly, we did not find HSP70 to be expressed at the cell surface before or after this treatment (Fig. 5A) . In addition to MICA and MICB, the NKG2D ligands ULBP2 and ULBP3 were found to be slightly induced after SAHA treatment (Fig. 5B) . [25] .
(B) The mean of relative lysis ϩ S.D. of L-MICA and L-con target cells by LAK cells stimulated for 8 days with IL-2 (100 U/ml), IL-2 plus rHSC70 (2 g/ml), or IL-2 plus rHSP70 (2 g/ml) was determined in four experiments. The percentage of specific lysis of L-MICA cells by IL-2 stimulated PBMCs at the highest effector to target ratio (50:1) was adjusted to 100% in each test and the relative lysis of the target cells by various effector cells at different effector to target ratios was calculated in this panel and the following panels (C-E). (C) The mean of relative lysis ϩ S.D. of L-MICA and L-con target cells by LAK cells stimulated for 8 days with IL-2 (100 U/ml), IL-2 plus rHSP70 (2 g/ml), or IL-2 plus LPS (10 ng/ml) was determined in six experiments. (D) The mean of relative lysis ϩ S.D. of L-MICA and L-con target cells by LAK cells stimulated for 8 days with IL-2 (100 U/ml), IL-2 plus rHSP70 (2 g/ml), or IL-2 plus Euk hHSP70 (2 g/ml) was determined in eight experiments. (E) The mean of relative lysis ϩ S.D. of L-MICA and L-con target cells by LAK cells stimulated for 8 days with IL-2 (100 U/ml), or IL-2 plus TKD (2 g/ml), or IL-2 plus the scrambled peptide NGL (2 g/ml) was determined in 15 (TKD) or 8 (NGL) experiments.
MICA/B induction on Ge melanoma cells improves their killing by LAK cells
MICA/B induction on target cells and TKD activation of NK cells act synergistically
In the following experiments, isolated human NK cells were cultured for 5 days without IL-2, with IL-2, or with IL-2 plus
Fig. 3 NK cells are the effector cells that are stimulated to kill MICAexpressing target cells by the HSP70-derived peptide TKD. (A) Flow cytometric analyses of PBMCs (before MACS separation) and NK cellenriched (NK ϩ ) as well as NK cell-depleted (NK
Ϫ ) cell populations was performed. The mean of the proportion of marker positive cells ϩ S.D. of 17 experiments is given. (B) The mean specific lysis Ϯ S.D. of triplicates of L-MICA and L-con target cells by isolated NK cells (NK
Although the focus was initially on the induction of CTL responses, it has been noticed that NK cell
Fig. 4 NK cells express increased amounts of granzyme B after stimulation with TKD. (A) MACS-enriched NK cells after 5 days culture with IL-2 (100 U/ml), or IL-2 (100 U/ml) plus TKD (2 g/ml), or IL-2 (100 U/ml) plus NGL (2 g/ml) were analysed by flow cytometry for the expression of CD56, CD94, CD16 and NKG2D. The mean of marker positive cells ϩ S.D. of 39 (IL-2), 34 (IL-2 plus TKD) or 10 (IL-2 plus NGL) experiments are given. (B) The mean ϩ S.D. of the specific MFI of NKG2D (MFI for the specific staining minus MFI for the isotype control) on NK cells cultured in the presence of IL-2 or IL-2 plus TKD is shown. (C) The mean ϩ S.D. of the specific MFI for granzyme B (MFI for the specific staining minus MFI for the staining with the secondary Ab alone) was analysed in eight experiments, and was determined by intracellular flow cytometry in NK cells cultured for 5 days with IL-2 (100 U/ml) or IL-2 (100 U/ml) plus TKD (2 g/ml).
depletion can also abrogate the efficacy of immunization with gp96 or HSP70 [26] . Furthermore, a perforin-dependent NK cell activity has been reported to be required to induce a CTL-mediated rejection of tumour cells engineered to secrete gp96 [27] . NK cells seem to be necessary for the adjuvant-like activity of HSP70 in the induction of CTL responses [28] . Consistent with these reports, it was recently observed that patients treated with autologous tumour-derived HSP70 or HSP96 undergo a significant boost of NK cell activity [29, 30] . [1] [2] [3] [4] [5] . HSPs might be a new component also in this system and contribute to the activation of NK cells. It has previously been described that HSP70 [9] and the HSP70-derived peptide TKD [19] can stimulate human NK cells to specifically kill tumour cells that express HSP70 at the plasma membrane [8] [10] which are known ligands for the welldefined activating NK receptor NKG2D [11, 12, 31] .
Thus, an initial NK cell-mediated lysis of tumour cells and/or NK cell-released cytokines might contribute to an efficient priming of tumour-specific CTL by HSPs. Importantly, not only T cells but also resting NK cells require activating signals to acquire their full effector functions
In addition to MICA and MICB, human NKG2D ligands include the UL16-binding proteins (ULBP) 1 to 4 [11, 12] . NKG2D ligands appear to be up-regulated in response to stress, such as heat shock [32, 33] , virus infection [11, 34] , or genotoxic stress [35] . They signal the presence of potentially dangerous cells to the immune system [36, 37] the stress-inducible HSP70 in contrast to the constitutively expressed HSC70. This finding confirms previous results obtained with human NK cells that were directed against HSP70 plasma membrane positive target cells [9] . In accordance with this observation, the peptide TKD, which is derived from HSP70 and is not present in the HSC70 protein due to a variation of two amino acids (TKDNNLLGKFELTG) [19, 24] [21, 42] , or on other cells which express HSP receptors [25] and cross-talk to NK cells, e.g. DCs [7] . Interestingly, MICA/B on DCs has been reported to be induced by IFN-␣ and subsequently stimulate NK cells [43] . Recently NK cell cytotoxicity by HSP70. However, it is also known that the generation of IFN-␥ does not necessarily parallel the cytotoxic function of NK cells [5] and both pathways might be stimulated by HSP70 in different ways. A study on patients vaccinated with the HSP gp96 suggested that both indirect and direct pathways of NK cell stimulation by HSPs exist [30] .
In [10] . Similar induction patterns have been described also for other cell lines [35] . Therefore, the combination of a proteotoxic stress leading to HSP70 expression and release and a genotoxic stress leading to MICA/B expression might act together and alert the innate immune system synergistically.
The adoptive transfer of HSP70 or TKD-activated NK cells is a promising new immunotherapy for tumours that express HSP70 at the plasma membrane, and this has been successfully evaluated in preclinical animal models [45] and also in a phase-Iclinical trial [46] . Because not all tumours express HSP70 at the cell surface, our finding that HSP70-stimulated NK cells can use NKG2D ligands as target structures substantially increases the spectrum of patients who might profit from this kind of tumour immunotherapy. 
